Streetbeat News

Analyst Ratings

IFRX

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on InflaRx (NASDAQ:IFRX), maintaining a price target of $9.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:29 am

ACET

HC Wainwright & Co. analyst Edward White maintains a 'Buy' rating on Adicet Bio (NASDAQ:ACET) but lowers the price target from $38 to $26.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:28 am

JAZZ

HC Wainwright & Co. analyst Oren Livnat has reiterated a 'Buy' rating on Jazz Pharmaceuticals, maintaining a price target of $204.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:27 am

TARS

HC Wainwright & Co. analyst Oren Livnat maintains a 'Buy' rating on Tarsus Pharmaceuticals (NASDAQ:TARS) but lowers the price target from $50 to $42.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:26 am

LCTX

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Lineage Cell Therapeutics (AMEX:LCTX) and maintained a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:25 am

EMAN

HC Wainwright & Co. analyst Kevin Dede has downgraded eMagin (AMEX:EMAN) from Buy to Neutral.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:22 am

GEVO

HC Wainwright & Co. analyst Amit Dayal maintains a 'Buy' rating on Gevo (NASDAQ:GEVO) but lowers the price target from $18 to $14.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:21 am

KOPN

HC Wainwright & Co. analyst Kevin Dede has reiterated a 'Buy' rating on Kopin (NASDAQ:KOPN) and maintained a $3 price target.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:18 am

RIOT

HC Wainwright & Co. analyst Mike Colonnese maintains a Buy rating on Riot Platforms (NASDAQ:RIOT) and raises the price target from $13.5 to $18.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:07 am

AEYE

HC Wainwright & Co. analyst Scott Buck has reiterated a 'Buy' rating on AudioEye (NASDAQ:AEYE) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 10:04 am